The trial of the matter entitled Elan Corporation PLC v. Andrx
Pharmaceuticals, Inc., Case No. 058- 0158, has been scheduled for
April 27, 2009, according to Watson Pharmaceuticals Inc.’s Form…
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.